PLATINE

Comprehensive Immnomonitoring Platform

PLATINE est accrédité par Lyonbiopôle

Identity card

Global budget: 10 050 k€

Public funding: 4 820 k€

Public funders: Conseil général de Rhône, FEDER Rhône-Alpes, Fonds Unique Interministériel (FUI) – DGCIS/Oséo, Grand Lyon, Grenoble Alpes Métropole, Région Rhône-Alpes

Call for projects: FUI (FUI AAP5)

Year start: 2008

Completed project (2012-06)


Accredited by the French competitiveness cluster Lyonbiopôle

More information: http://www.platine-lab.com/


Strategic business area: Human Medicines, Immunomonitoring

Application fields: Allergology, Autoimmune diseases, Cardiovascular diseases, Dermocosmetics, Genetic / Rare diseases, Geriatrics, Infectious diseases, Inflammatory diseases, Health & Environment, Metabolic diseases, Nutrition / Food, Oncology, Orphan diseases, Pediatrics

Technological approaches / Keywords: Biologics, Cell model / Animal model, Functional Screening / Drug discovery, Immunotherapy, In silico modeling

Stage of development at the beginning of the project:

Abstract

PLATINE aims to identify, develop and validate efficacy and safety biomarkers for new therapeutic molecules, especially immunomodulating drugs. PLATINE relies on proven conventional immunomonitoring techniques, as well as on innovative methods. PLATINE’ scientific team monitored successfully some of the partner’s molecules during their development and clinical validation steps. These first results have been the basis to develop a dedicated offer to other biotechnology and pharmaceuticals players, developing immuno-modulatory therapeutics, and thus consolidating PLATINE’s experience.


Objectives

Short-term - To become a recognized player in the field of immune-assays - To provide services complying with GLP - Rapidly grow the activity of services to the Healthcare industry Mid-term - Always offer up to date technologies to monitor immune responses during immunomodulatory therapeutic developments - Identify and/or validate new predictive biomarkers - Become a partner of choice for assay development and validation


Innovative assets
Highlights
Actual results
Perspectives

Innovative assets

Platine’s team brings over 60 years of cumulated research in the field of immunology (see our publications), and continues strengthening its scientific expertise thanks to its frequent interactions with world-class immunologists and clinicians

En poursuivant votre navigation sur notre site, vous acceptez l'utilisation des cookies et la collecte de vos données et informations personnelles par Lyonbiopôle, dans les finalités de mesurer le trafic sur le site Web, de fournir des statistiques et de vous proposer des contenus adaptés à vos centres d’intérets. Pour exercer vos droits d'accès, de rectification, d'opposition, de suppression et de portabilité, conformément au règlement général sur la protection des données (UE n°2016/679), vous etes informés que vous pouvez envoyer votre demande à dpo@lyonbiopole.com. Plus de détails sont disponibles en cliquant ici J'accepte